All In Biotech

Drug Trial Radar · NCT05764642

A Study of Renal Microvessel Imaging for Chronic Kidney Disease

Renal Microvessel Imaging for Characterization of Chronic Kidney Disease

Last checked: Nov 20, 2026Latest source record: Sep 11, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Enrolling by invitation

Status

Enrolling by invitation

Enrollment

186

Planned (sponsor's estimate)

Start

Aug 9, 2023

Primary completion

Apr 1, 2028

Study completion Apr 2028

Sponsor

Lead sponsor
Mayo ClinicAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
First posted
Mar 10, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Diagnostic
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this research is to study the efficacy of ultrasound microvessel imaging for evaluation of Chronic Kidney Disease. Definity is an ultrasound contrast agent currently approved by the FDA for use on the heart, liver, and urinary tract. This study will look at its effectiveness on the kidney.

Conditions

  • Healthy
  • Chronic Kidney Diseases

Interventions

  • DefinityDrug

    Ultrasound contrast agent administered intravenously

  • Super-resolution ultrasound imagingDiagnostic test

    Imaging technology for microvessel imaging. This technology localizes and tracks individual microbubbles (FDA approved ultrasound contrast agents) to map microvessel morphology and flow speed at a spatial resolution about 10 times higher than conventional ultrasound imaging.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Renal cortex microvessel densityTime frame: Baseline
  2. Renal cortex microvessel diameterTime frame: Baseline
  3. Renal blood flow velocityTime frame: Baseline

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Mayo Clinic Florida

    Jacksonville, Florida

  • Mayo Clinic Minnesota

    Rochester, Minnesota

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.